Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study.
Galland J, Thoreau B, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Boreiro B, Mangin O, Sellier PO, Mouly S, Kevorkian JP, Siguret V; Lariboisière COVID Group; Vodovar D, Sene D. Galland J, et al. Among authors: regard l. Eur J Haematol. 2021 Aug;107(2):190-201. doi: 10.1111/ejh.13638. Epub 2021 May 24. Eur J Haematol. 2021. PMID: 34288162 Free PMC article.
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
Thoreau B, Galland J, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Borrero B, Mangin O, Sellier PO, Siguret V, Mouly S, Kevorkian JP, Lariboisière Covid Group, Vodovar D, Sene D. Thoreau B, et al. Among authors: regard l. Viruses. 2021 Apr 26;13(5):758. doi: 10.3390/v13050758. Viruses. 2021. PMID: 33926038 Free PMC article.
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
Chouchana L, Boujaafar S, Gana I, Preta LH, Regard L, Legendre P, Azoulay C, Canouï E, Zerbit J, Carlier N, Terrier B, Kernéis S, Batista R, Treluyer JM, Zheng Y, Benaboud S. Chouchana L, et al. Among authors: regard l. Ther Drug Monit. 2021 Feb 1;43(1):131-135. doi: 10.1097/FTD.0000000000000838. Ther Drug Monit. 2021. PMID: 33230045 Free PMC article.
COVID-19 after 18 months: Where do we stand?
Chassagnon G, Regard L, Soyer P, Revel MP. Chassagnon G, et al. Among authors: regard l. Diagn Interv Imaging. 2021 Sep;102(9):491-492. doi: 10.1016/j.diii.2021.06.003. Epub 2021 Jun 18. Diagn Interv Imaging. 2021. PMID: 34183299 Free PMC article. No abstract available.
A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.
Joumaa H, Regard L, Carlier N, Chassagnon G, Alabadan E, Canouï E, L'honneur A, Rozenberg F, Burgel PR, Roche N. Joumaa H, et al. Among authors: regard l, l honneur a. Respir Med Res. 2020 Nov;78:100780. doi: 10.1016/j.resmer.2020.100780. Epub 2020 Jul 15. Respir Med Res. 2020. PMID: 32759053 Free PMC article. No abstract available.
34 results